Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients

Clinical Cancer Research

Volumn 10, Issue 10, 2004, Pages 3457-3464

  Gangnus, Rainer ^a,b,d   Langer, Sabine ^a,b   Breit, Elisabeth ^c   Pantel, Klaus ^c   Speicher, Michael R ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d PALM Microlaser Technologies AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CANCER STAGING; CELL PROLIFERATION; CELL VIABILITY; CHROMOSOME NUMBER; COMPARATIVE GENOMIC HYBRIDIZATION; DNA FINGERPRINTING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STEM CELL;

ADULT; AGED; BONE MARROW; BONE MARROW CELLS; BREAST NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHROMOSOME MAPPING; CLUSTER ANALYSIS; FEMALE; GENOME; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KERATINS; LASERS; MICROSATELLITE REPEATS; MIDDLE AGED; MULTIGENE FAMILY; NEOPLASM METASTASIS; NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 2542474181     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0818     Document Type: Article

References (22)

1. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science (Wash. DC) 1977;197:893-5.
2. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature (Lond.) 1980;283:139-46.
3. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003;3:453-8.
4. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond.) 2002;415:530-6.
5. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
6. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
7. Bernards R, Weinberg RA. A progression puzzle. Nature (Lond.) 2002;418:823.
8. van't Veer LJ, Weigelt B. Road map to metastasis. Nat Med 2003;9:999-1000.
9. Pantel K, Braun S. Molecular determinants of occult metastatic tumor cells in bone marrow. Clin Breast Cancer 2001;2:222-8.
10. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst (Bethesda) 1999;91:1113-24.
11. Braun S, Pantel K, Müller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000;342:525-33.
12. Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmüller G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci USA 1999;96:4494-9.
13. Schmidt-Kittler O, Ragg T, Daskalakis A, et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 2003;100:7737-42.
14. Gray JW. Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors. Cancer Cell 2003;4:4-6.
15. Solakoglu O, Maierhofer C, Lahr G, et al. Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors. Proc Natl Acad Sci USA 2002;99:2246-51.
16. Pantel K, Dickmanns A, Zippelius A, et al. Establishment of carcinoma cell lines from bone marrow of patients with minimal residual cancer: a novel source of tumor cell vaccines. J Natl Cancer Inst (Bethesda) 1995;87:1160-8.
17. Schütze K, Lahr G. Identification of expressed genes by laser-mediated manipulation of single cells. Nat Biotechnol 1998;16:737-42.
18. Klein CA, Blankenstein TJ, Schmidt-Kittler O, et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 2002;360:683-9.
19. Stoecklein NH, Erbersdobler A, Schmidt-Kittler O, et al. SCOMP is superior to degenerated oligonucleotide primed-polymerase chain reaction for global amplification of minute amounts of DNA from microdissected archival tissue samples. Am J Pathol 2002;161:43-51.
20. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-8.
21. Albertson DG, Collins C, McCormick F, Gray JW. Chromosome aberrations in solid tumors. Nat Genet 2003;34:369-76.
22. Borgen E, Naume B, Nesland JM, et al. Standardization of the immunocytochemical detection of cancer cells in BM and blood: 1. Establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 1999;1:377-88.